Works matching DE "VASCULAR endothelial growth factor receptors"

Results: 1840
    1

    Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.1001217
    By:
    • Schmitz-Winnenthal, Friedrich H;
    • Weitz, Jürgen;
    • Ulrich, Alexis;
    • Buechler, Markus W;
    • Pianka, Frank;
    • Klaiber, Ulla;
    • Diener, Markus;
    • Leowardi, Christine;
    • Schimmack, Simon;
    • Sisic, Leila;
    • Keller, Anne-Valerie;
    • Koc, Ruhan;
    • Knebel, Philipp;
    • Schmidt, Thomas;
    • Hohmann, Nicolas;
    • Mikus, Gerd;
    • Haefeli, Walter E;
    • Niethammer, Andreas G;
    • Breiner, Klaus M;
    • Friedrich, Tobias
    Publication type:
    Article
    2
    3
    4

    Trick and treat.

    Published in:
    OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.27811
    By:
    • Boisgerault, Nicolas;
    • Vile, Richard G
    Publication type:
    Article
    5

    Trial Watch.

    Published in:
    OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27048
    By:
    • Vacchelli, Erika;
    • Aranda, Fernando;
    • Eggermont, Alexander;
    • Galon, Jérôme;
    • Sautès-Fridman, Catherine;
    • Zitvogel, Laurence;
    • Kroemer, Guido;
    • Galluzzi, Lorenzo
    Publication type:
    Article
    6
    7
    8
    9
    10

    VEGF family in cortical development.

    Published in:
    Neural Development, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13064-025-00199-5
    By:
    • Halim, Alexander;
    • Kuo, Hung-Chih;
    • Hou, Pei-Shan
    Publication type:
    Article
    11

    Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKI.

    Published in:
    BMC Nephrology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12882-025-04169-1
    By:
    • Shi, Audrey A.;
    • Andrawis, Anna Simone;
    • Biswas, Aditya;
    • Wilson, Francis P.;
    • Obeid, Wassim;
    • Philbrook, Heather Thiessen;
    • Go, Alan S.;
    • Ikizler, T. Alp;
    • Siew, Edward D.;
    • Chinchilli, Vernon M.;
    • Hsu, Chi-Yuan;
    • Garg, Amit X.;
    • Reeves, W. Brian;
    • Prince, David K.;
    • Bhatraju, Pavan;
    • Coca, Steve G.;
    • Liu, Kathleen D.;
    • Kimmel, Paul L.;
    • Kaufman, James S.;
    • Wurfel, Mark W.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension.

    Published in:
    Basic Research in Cardiology, 2020, v. 115, n. 6, p. N.PAG, doi. 10.1007/s00395-020-0811-5
    By:
    • Winter, Max-Paul;
    • Sharma, Smriti;
    • Altmann, Johanna;
    • Seidl, Veronika;
    • Panzenböck, Adelheid;
    • Alimohammadi, Arman;
    • Zelniker, Thomas;
    • Redwan, Bassam;
    • Nagel, Felix;
    • Santer, David;
    • Stieglbauer, Alexander;
    • Podesser, Bruno;
    • Sibilia, Maria;
    • Helbich, Thomas;
    • Prager, Gerald;
    • Ilhan-Mutlu, Aysegül;
    • Preusser, Matthias;
    • Lang, Irene M.
    Publication type:
    Article
    24
    25
    26
    27

    Soluble FMS-like tyrosine kinase-1: An overview.

    Published in:
    International Journal of Medical Biochemistry, 2023, v. 6, n. 2, p. 117, doi. 10.14744/ijmb.2023.66933
    By:
    • Selvarajan, Sathya;
    • Ramalingam, Jothimalar;
    • Venugopal, Veena
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    A retrospective study of the efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR-TKI monotherapy for PD-L1-positive EGFR-mutant non-small cell lung cancer: North Japan Lung Cancer Study Group 2202.

    Published in:
    Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13920
    By:
    • MINEHIKO INOMATA;
    • YOSUKE KAWASHIMA;
    • RYOTA SAITO;
    • DAISUKE MORINAGA;
    • HITOMI NOGAWA;
    • MASAMICHI SATO;
    • YOHEI SUZUK;
    • SATORU YANAGISAWA;
    • TAKASHI KIKUCHI;
    • DAISUKE JINGU;
    • NARUO YOSHIMURA;
    • TOSHIYUKI HARADA;
    • EISAKU MIYAUCHI
    Publication type:
    Article
    46

    Biomarkers for anti-vascular endothelial growth factor drugs.

    Published in:
    Oncology Letters, 2022, v. 24, n. 6, p. N.PAG, doi. 10.3892/ol.2022.13583
    By:
    • Kuriyama, Sho;
    • Yamada, Takeshi;
    • Matsuda, Akihisa;
    • Takahashi, Goro;
    • Iwai, Takuma;
    • Takeda, Kohki;
    • Ueda, Koji;
    • Miyasaka, Toshimitsu;
    • Yokoyama, Yasuyuki;
    • Shinji, Seiichi;
    • Sonoda, Hiromichi;
    • Ohta, Ryo;
    • Yonaga, Kazuhide;
    • Kanaka, Shintaro;
    • Yoshida, Hiroshi
    Publication type:
    Article
    47
    48
    49
    50